More than a month after interns and residents left hospitals in protest against the government's expansion of medical school enrollment quota, a university hospital professor who kept working at the hospital, has died, shocking the medical community.Pusan National University Hospital (PNUH) said a p
The merger between the Hanmi Pharmaceutical Group and the OCI Group has been put to brakes, as Hanmi Science’s largest individual shareholder declared his support for the deceased group founder’s two sons, who oppose the merger.Hanyang Precision Chairman Shin Dong-guk, a close confidant of the late
In vitro diagnostics company Precision Biosensor has begun commercializing personalized diagnostic equipment, Egoo Health System, by collaborating with its Danish partner Qlife.Qlife, which was listed on the Nasdaq First North Growth Market, an alternative stock exchange for small- and mid-sized gro
Celltrion said Monday it has received a recommendation from the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) to grant the marketing authorization for the full-label application of CT-P39, a biosimilar to Xolair (omalizumab).CT-P39's original drug, Xolair, i
VaxCell-Bio said it submitted an international patent for a new multiple myeloma treatment known as chimeric-antigen receptor-marrow-infiltrating lymphocytes (CAR-MILs) in Europe and China.The submission marks a significant step becasue it is the first time a Korean firm has sought international pat
Lee Woo-hyun, CEO of OCI Holdings, the largest shareholder of Bukwang Pharmaceutical, spoke about the current status of the company’s new drug development and possible future cooperation with the Hanmi Pharmaceutical Group at Bukwang Pharmaceutical’s shareholders meeting.Bukwang Pharmaceutical held
Geo-Young, Korea's largest pharmaceutical distributor, said Friday that it has signed a third-party logistics (3PL) contract with Samsung Bioepis for biosimilar drugs and started shipping the first batch.It was the first business agreement between the two companies, which calls for Geo-Young to carr
The government said it could administratively prohibit resigned interns and residents from obtaining medical licenses in the U.S.On Friday, the Ministry of Health and Welfare said so at a regular briefing of the Central Disaster and Safety Countermeasures Headquarters to deal with junior physicians’
Korea's healthcare system is deformed, with private medical institutions accounting for over 90 percent of the total. This system is unparalleled worldwide, as the private market overwhelms the public health system. National health insurance exists, but the health authorities have failed to appropri
Medical costs for cancer treatment exceeded 10 trillion won ($7.5 billion) for the first time in Korea last year.According to the Health Insurance Review and Assessment Service (HIRA) analysis of malignant neoplasm treatment status over the past five years, the number of cancer increased by 18.1 per
A Yonsei University research team has uncovered that the quality and length of a woman's hair may play a significant role in the sexual dynamics of a marriage.The survey conducted on 204 couples in Korea suggests that women with long and high-quality hair experience more frequent sexual intercourse
Large hospitals have been paralyzed due to the government's unilateral push to increase the medical school enrollment quota for a month now.In other words, for over a month, specialists and professors have been working around the clock to fill the healthcare void left by the departure of interns, re
"My wife passed away from lung cancer last year. I never thought she would get lung cancer because she was a non-smoker and was so healthy that she hardly caught a cold. She went to her annual check-ups and never missed a chest X-ray, but she lived less than three years after the diagnosis of stage
Hanmi Group, led by Chairman Song Young-sook, criticized the vision put forth by her sons, Hanmi Pharm CEO and Coree Group Chairman Lim Jong-yoon and Hanmi Fine Chemical CEO Lim Jong-hoon, who oppose the merger between Hanmi Group and OCI Group.The criticism came in response to a press conference he
"We're not asking for health insurance benefits. We are asking for the opportunity to be treated in Korea, even at our own expense."Korean neuroendocrine tumor patients said so after the Health Insurance Review and Assessment Service (HIRA) said last Friday that it is difficult to lift the limit of
Amid mounting concerns about inadequate medical student education due to a drastic increase in their enrollment quota from 2025, government officials expressed an intention to obligate the sharing of cadavers for anatomy dissection among schools if supply fails to meet demand.Noting that a corpse ca
Medical AI company AITRICS said Thursday that it has raised Series B funding totaling 27.1 billion won ($20.4 million) from nine Korean and foreign venture capital firms.For the Series B round, existing investors like Premier Partners, BNH Investment, and BSK Investment made follow-on investments, w
Gilead's Sunlenca (lenacapavir), which has been attracting attention for treating human immunodeficiency virus (HIV) with twice-yearly injections, will likely be administered for the first time in Korea.On Tuesday, the Ministry of Food and Drug Safety (MFDS) approved the therapeutic use of Sunlenca
Novartis Korea has received a three-month import suspension order from the Ministry of Food and Drug Safety (MFDS) for Simulect Injection (basiliximab) due to a foreign substance contamination incident last year.Novartis Korea said it would do its best to supply the product so patients are not harme
In the midst of a contentious battle for control over Hanmi Group, Lim Jong-yoon and Lim Jong-hoon -- the sons of the company founder and the late Lim Sung-ki -- appealed for shareholders' support and promised to elevate Hanmi Pharm into a powerhouse capable of generating 1 trillion won ($754.2 mill